193 related articles for article (PubMed ID: 33387040)
1. Overexpressed CA12 has prognostic value in pancreatic cancer and promotes tumor cell apoptosis via NF-κB signaling.
Du Y; Xin Z; Liu T; Xu P; Mao F; Yao J
J Cancer Res Clin Oncol; 2021 May; 147(5):1557-1564. PubMed ID: 33387040
[TBL] [Abstract][Full Text] [Related]
2. Interplay Between Gemcitabine and Erlotinib Over Pancreatic Adenocarcinoma Cells.
Torres C; Linares A; Alejandre MJ; Palomino-Morales RJ; Delgado JR; Perales S
Pancreas; 2016 Feb; 45(2):269-80. PubMed ID: 26495790
[TBL] [Abstract][Full Text] [Related]
3. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.
Jiang Y; Feng E; Sun L; Jin W; You Y; Yao Y; Xu Y
Biomed Pharmacother; 2017 Nov; 95():685-691. PubMed ID: 28886528
[TBL] [Abstract][Full Text] [Related]
4. Matrine injection inhibits pancreatic cancer growth via modulating carbonic anhydrases- a network pharmacology-based study with in vitro validation.
Xu PL; Cheng CS; Jiao JY; Chen H; Chen Z; Li P
J Ethnopharmacol; 2022 Apr; 287():114691. PubMed ID: 34597654
[TBL] [Abstract][Full Text] [Related]
5. Over-expressed RHEB promotes the progression of pancreatic adenocarcinoma.
Tan J; Liu W; Li J; Zhang X; Liu Y; Yuan Y; Song Z
Life Sci; 2021 Jul; 277():119462. PubMed ID: 33831427
[TBL] [Abstract][Full Text] [Related]
6.
Kuang W; Wang X; Ding J; Li J; Ji M; Chen W; Wang L; Yang P
Front Immunol; 2022; 13():805311. PubMed ID: 35154122
[TBL] [Abstract][Full Text] [Related]
7. miR‑32‑5p suppresses the proliferation and migration of pancreatic adenocarcinoma cells by targeting TLDC1.
Yuan P; Tang C; Chen B; Lei P; Song J; Xin G; Wang Z; Hui Y; Yao W; Wang G; Zhao G
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34468015
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-1469-5p promotes the invasion and proliferation of pancreatic cancer cells via direct regulating the NDRG1/NF-κB/E-cadherin axis.
Liu J; Zhu C; Zhang L; Lu H; Wang Z; Lv J; Fan C
Hum Cell; 2020 Oct; 33(4):1176-1185. PubMed ID: 32757096
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of NF-κB activating protein promotes pancreatic cancer growth and metastasis through mTOR signaling pathway.
Xu X; Hou D; Wang Y; Zhang J; Hei Y; Wang B; Tian S; Zhang Y; Wang F
Mol Biol Rep; 2023 Sep; 50(9):7501-7513. PubMed ID: 37486443
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of ARHI on pancreatic cancer cells and NF-κB activity.
Hu YQ; Si LJ; Ye ZS; Lin ZH; Zhou JP
Mol Med Rep; 2013 Apr; 7(4):1180-4. PubMed ID: 23447002
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological features, prognostic significance, and associated tumor cell functions of family with sequence similarity 111 member B in pancreatic adenocarcinoma.
Gong Q; Dong Q; Zhong B; Zhang T; Cao D; Zhang Y; Ma D; Cai X; Li Z
J Clin Lab Anal; 2022 Dec; 36(12):e24784. PubMed ID: 36408702
[TBL] [Abstract][Full Text] [Related]
12. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
Xia B; Yang S; Liu T; Lou G
Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
[TBL] [Abstract][Full Text] [Related]
13. COL10A1 promotes tumorigenesis by modulating CD276 in pancreatic adenocarcinoma.
Xu Q; Zheng J; Su Z; Chen B; Gu S
BMC Gastroenterol; 2023 Nov; 23(1):397. PubMed ID: 37974070
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of CBX3 in Pancreatic Adenocarcinoma Promotes Cell Cycle Transition-Associated Tumor Progression.
Chen LY; Cheng CS; Qu C; Wang P; Chen H; Meng ZQ; Chen Z
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29903985
[TBL] [Abstract][Full Text] [Related]
15. ARHGAP25 Inhibits Pancreatic Adenocarcinoma Growth by Suppressing Glycolysis via AKT/mTOR Pathway.
Huang WK; Chen Y; Su H; Chen TY; Gao J; Liu Y; Yeh CN; Li S
Int J Biol Sci; 2021; 17(7):1808-1820. PubMed ID: 33994864
[TBL] [Abstract][Full Text] [Related]
16. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
[TBL] [Abstract][Full Text] [Related]
17. Functional inhibition of lactate dehydrogenase suppresses pancreatic adenocarcinoma progression.
Cheng CS; Tan HY; Wang N; Chen L; Meng Z; Chen Z; Feng Y
Clin Transl Med; 2021 Jun; 11(6):e467. PubMed ID: 34185423
[TBL] [Abstract][Full Text] [Related]
18. PLAGL1 is associated with prognosis and cell proliferation in pancreatic adenocarcinoma.
Liang X; Fu Z; Tang L; Zheng M; Chen D; Liu A; Shi L; Yang L; Shao C; Dong X
BMC Gastroenterol; 2023 Jan; 23(1):2. PubMed ID: 36600208
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of zinc transporter ZIP4, ZIP11, ZnT1, and ZnT6 predicts poor prognosis in pancreatic cancer.
Zhu B; Huo R; Zhi Q; Zhan M; Chen X; Hua ZC
J Trace Elem Med Biol; 2021 May; 65():126734. PubMed ID: 33631610
[TBL] [Abstract][Full Text] [Related]
20. AMP‑activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas.
Xu H; Mao J; Yang X; Chen F; Song Z; Fei J; Chen W; Zhong Z; Wang X
Mol Med Rep; 2020 Nov; 22(5):4329-4339. PubMed ID: 33000197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]